Pharvaris Statistics

Total Valuation

Pharvaris has a market cap or net worth of $1.06 billion. The enterprise value is $721.08 million.

Market Cap	1.06B
Enterprise Value	721.08M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Pharvaris has 54.23 million shares outstanding. The number of shares has increased by 43.84% in one year.

Current Share Class	54.23M
Shares Outstanding	54.23M
Shares Change (YoY)	+43.84%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	9.45%
Owned by Institutions (%)	34.54%
Float	18.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.21
P/TBV Ratio	3.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.08, with a Debt / Equity ratio of 0.00.

Current Ratio	19.08
Quick Ratio	18.81
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -58.77% and return on invested capital (ROIC) is -35.47%.

Return on Equity (ROE)	-58.77%
Return on Assets (ROA)	-33.10%
Return on Capital (ROIC)	-35.47%
Revenue Per Employee	n/a
Profits Per Employee	-$1.80M
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Pharvaris has paid $1.49 million in taxes.

Income Tax	1.49M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.79% in the last 52 weeks. The beta is -3.17, so Pharvaris's price volatility has been lower than the market average.

Beta (5Y)	-3.17
52-Week Price Change	-26.79%
50-Day Moving Average	21.16
200-Day Moving Average	20.08
Relative Strength Index (RSI)	47.85
Average Volume (20 Days)	110,920

Short Selling Information

The latest short interest is 202,153, so 0.37% of the outstanding shares have been sold short.

Short Interest	202,153
Short Previous Month	183,253
Short % of Shares Out	0.37%
Short % of Float	1.07%
Short Ratio (days to cover)	1.49

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-142.51M
Pretax Income	-114.68M
Net Income	-147.46M
EBITDA	-142.60M
EBIT	-142.51M
Earnings Per Share (EPS)	-$2.86

Full Income Statement

Balance Sheet

The company has $340.39 million in cash and $130,425 in debt, giving a net cash position of $340.26 million or $6.27 per share.

Cash & Cash Equivalents	340.39M
Total Debt	130,425
Net Cash	340.26M
Net Cash Per Share	$6.27
Equity (Book Value)	331.01M
Book Value Per Share	6.10
Working Capital	330.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$121.55 million and capital expenditures -$452,319, giving a free cash flow of -$114.11 million.

Operating Cash Flow	-121.55M
Capital Expenditures	-452,319
Free Cash Flow	-114.11M
FCF Per Share	-$2.10

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pharvaris does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.84%
Shareholder Yield	-43.84%
Earnings Yield	-13.89%
FCF Yield	-10.75%

Analyst Forecast

The average price target for Pharvaris is $40.60, which is 107.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.60
Price Target Difference	107.46%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2